An inhibitor's-eye view of the atp-binding site of CDKs in different regulatory states

ACS Chemical Biology

Volumn 9, Issue 6, 2014, Pages 1251-1256

  Echalier, Aude ^a,c   Hole, Alison J ^a,d   Lolli, Graziano ^b   Endicott, Jane A ^a,e   Noble, Martin E M ^a,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

^c CNRS   (France)

^d Newcastle Cancer Centre Northern Institute for Cancer Research Newcastle University ^*  (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIN A; CYCLIN A2; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN T1; MONOMER; ENZYME INHIBITOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; FLUOROMETRY; PRIORITY JOURNAL; SF9 CELL LINE; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; BINDING SITES; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 84903127470     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500135f     Document Type: Article

References (37)

1. Zhang, J., Yang, P. L., and Gray, N. S. (2009) Targeting cancer with small molecule kinase inhibitors Nat. Rev. Cancer 9, 28-39
2. Fabbro, D., Cowan-Jacob, S. W., Mobitz, H., and Martiny-Baron, G. (2012) Targeting cancer with small-molecular-weight kinase inhibitors Methods Mol. Biol. (N. Y.) 795, 1-34
3. Cohen, P. (2009) Targeting protein kinases for the development of anti-inflammatory drugs Curr. Opin. Cell Biol. 21, 317-324
4. Janne, P. A., Gray, N., and Settleman, J. (2009) Factors underlying sensitivity of cancers to small-molecule kinase inhibitors Nat. Rev. Drug Discovery 8, 709-723
5. Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., Faraoni, R., Floyd, M., Hunt, J. P., Lockhart, D. J., Milanov, Z. V., Morrison, M. J., Pallares, G., Patel, H. K., Pritchard, S., Wodicka, L. M., and Zarrinkar, P. P. (2008) A quantitative analysis of kinase inhibitor selectivity Nat. Biotechnol. 26, 127-132
6. Smyth, L. A. and Collins, I. (2009) Measuring and interpreting the selectivity of protein kinase inhibitors J. Chem. Biol. 2, 131-151
7. Huse, M. and Kuriyan, J. (2002) The conformational plasticity of protein kinases Cell 109, 275-282 (Pubitemid 34606870)
8. Cowan-Jacob, S. W. (2006) Structural biology of protein tyrosine kinases Cell. Mol. Life Sci. 63, 2608-2625 (Pubitemid 44800715)
9. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome Science 298, 1912-1934 (Pubitemid 35425239)
10. Morgan, D. O. (2007) The Cell Cycle, Principles of Control (Primers in Biology), New Science Press Ltd., London.
11. Bartkowiak, B., Liu, P., Phatnani, H. P., Fuda, N. J., Cooper, J. J., Price, D. H., Adelman, K., Lis, J. T., and Greenleaf, A. L. (2010) CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1 Genes Dev. 24, 2303-2316
12. Chen, H. H., Wong, Y. H., Geneviere, A. M., and Fann, M. J. (2007) CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing Biochem. Biophys. Res. Commun. 354, 735-740
13. Noble, M. E., Endicott, J. A., and Johnson, L. N. (2004) Protein kinase inhibitors: insights into drug design from structure Science 303, 1800-1805 (Pubitemid 38374863)
14. Ali, S., Heathcote, D. A., Kroll, S. H., Jogalekar, A. S., Scheiper, B., Patel, H., Brackow, J., Siwicka, A., Fuchter, M. J., Periyasamy, M., Tolhurst, R. S., Kanneganti, S. K., Snyder, J. P., Liotta, D. C., Aboagye, E. O., Barrett, A. G., and Coombes, R. C. (2009) The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity Cancer Res. 69, 6208-6215
15. Pavletich, N. P. (1999) Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors J. Mol. Biol. 287, 821-828 (Pubitemid 29188868)
16. Echalier, A., Endicott, J. A., and Noble, M. E. (2010) Recent developments in cyclin-dependent kinase biochemical and structural studies Biochim. Biophys. Acta 1804, 511-519
17. De Bondt, H. L., Rosenblatt, J., Jancarik, J., Jones, H. D., Morgan, D. O., and Kim, S. H. (1993) Crystal structure of cyclin-dependent kinase 2 Nature 363, 595-602 (Pubitemid 23227617)
18. Brown, N. R., Noble, M. E., Endicott, J. A., and Johnson, L. N. (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases Nat. Cell Biol. 1, 438-443 (Pubitemid 129502811)
19. Takaki, T., Echalier, A., Brown, N. R., Hunt, T., Endicott, J. A., and Noble, M. E. (2009) The structure of CDK4/cyclin D3 has implications for models of CDK activation Proc. Natl. Acad. Sci. U.S.A. 106, 4171-4176
20. Day, P. J., Cleasby, A., Tickle, I. J., O'Reilly, M., Coyle, J. E., Holding, F. P., McMenamin, R. L., Yon, J., Chopra, R., Lengauer, C., and Jhoti, H. (2009) Crystal structure of human CDK4 in complex with a D-type cyclin Proc. Natl. Acad. Sci. U.S.A. 106, 4166-4170
21. Tarricone, C., Dhavan, R., Peng, J., Areces, L. B., Tsai, L. H., and Musacchio, A. (2001) Structure and regulation of the CDK5-p25(nck5a) complex Mol. Cell 8, 657-669
22. Schneider, E. V., Bottcher, J., Blaesse, M., Neumann, L., Huber, R., and Maskos, K. (2011) The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder J. Mol. Biol. 412, 251-266
23. Lo, M. C., Aulabaugh, A., Jin, G., Cowling, R., Bard, J., Malamas, M., and Ellestad, G. (2004) Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery Anal. Biochem. 332, 153-159 (Pubitemid 39099482)
24. Najmanovich, R. J., Allali-Hassani, A., Morris, R. J., Dombrovsky, L., Pan, P. W., Vedadi, M., Plotnikov, A. N., Edwards, A., Arrowsmith, C., and Thornton, J. M. (2007) Analysis of binding site similarity, small-molecule similarity and experimental binding profiles in the human cytosolic sulfotransferase family Bioinformatics 23, e104-109
25. Merckx, A., Echalier, A., Langford, K., Sicard, A., Langsley, G., Joore, J., Doerig, C., Noble, M., and Endicott, J. (2008) Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design Structure 16, 228-238 (Pubitemid 351222652)
26. Brown, N. R., Noble, M. E., Lawrie, A. M., Morris, M. C., Tunnah, P., Divita, G., Johnson, L. N., and Endicott, J. A. (1999) Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity J. Biol. Chem. 274, 8746-8756 (Pubitemid 29164672)
27. Russo, A. A., Jeffrey, P. D., and Pavletich, N. P. (1996) Structural basis of cyclin-dependent kinase activation by phosphorylation Nat. Struct. Biol. 3, 696-700 (Pubitemid 26260060)
28. Fang, Z., Grutter, C., and Rauh, D. (2013) Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features ACS Chem. Biol. 8, 58-70
29. Schachter, M. M., Merrick, K. A., Larochelle, S., Hirschi, A., Zhang, C., Shokat, K. M., Rubin, S. M., and Fisher, R. P. (2013) A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression Mol. Cell 50, 250-260
30. Baumli, S., Lolli, G., Lowe, E. D., Troiani, S., Rusconi, L., Bullock, A. N., Debreczeni, J. E., Knapp, S., and Johnson, L. N. (2008) The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation EMBO J. 27, 1907-1918
31. Lolli, G., Lowe, E. D., Brown, N. R., and Johnson, L. N. (2004) The crystal structure of human CDK7 and its protein recognition properties Structure 12, 2067-2079 (Pubitemid 39469404)
32. Matulis, D., Kranz, J. K., Salemme, F. R., and Todd, M. J. (2005) Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor Biochemistry 44, 5258-5266 (Pubitemid 40471238)
33. Bullock, A. N., Debreczeni, J. E., Fedorov, O. Y., Nelson, A., Marsden, B. D., and Knapp, S. (2005) Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase J. Med. Chem. 48, 7604-7614 (Pubitemid 41698801)
34. Bain, J., McLauchlan, H., Elliott, M., and Cohen, P. (2003) The specificities of protein kinase inhibitors: an update Biochem. J. 371, 199-204 (Pubitemid 36458094)
35. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R., and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update Biochem. J. 408, 297-315
36. Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem. J. 351, 95-105
37. Pratt, D. J., Bentley, J., Jewsbury, P., Boyle, F. T., Endicott, J. A., and Noble, M. E. (2006) Dissecting the determinants of cyclin-dependent kinase 2 and cyclin-dependent kinase 4 inhibitor selectivity J. Med. Chem. 49, 5470-5477